Pathstone Family Office’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-29	Closed	-$2K	–	776
2019 Q1	$2K	Sell	29 -90	-76%	-$6.21K	﹤0.01%	777
2018 Q4	$10K	Buy	+119	New	+$10K	﹤0.01%	325
2017 Q2	–	Sell	-6	Closed	–	–	532
2017 Q1	$0	Buy	+6	New	–	﹤0.01%	602